Difference between revisions of "Gene Therapy"

From Biolecture.org
imported>Ilsun yun
imported>Ilsun yun
 
Line 16: Line 16:
  
 
<p><a href="https://en.wikipedia.org/wiki/Genome_editing" title="Genome editing">Gene editing</a>&nbsp;is a potential approach to alter the human genome to treat genetic diseases,<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-34">[34]</a></sup>&nbsp;viral diseases,<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-35">[35]</a></sup>&nbsp;and cancer.<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-36">[36]</a></sup>&nbsp;As of 2016&nbsp;these approaches were still years from being medicine.<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-37">[37]</a></sup><sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-38">[38]</a></sup></p>
 
<p><a href="https://en.wikipedia.org/wiki/Genome_editing" title="Genome editing">Gene editing</a>&nbsp;is a potential approach to alter the human genome to treat genetic diseases,<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-34">[34]</a></sup>&nbsp;viral diseases,<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-35">[35]</a></sup>&nbsp;and cancer.<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-36">[36]</a></sup>&nbsp;As of 2016&nbsp;these approaches were still years from being medicine.<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-37">[37]</a></sup><sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-38">[38]</a></sup></p>
 +
 +
<h2>Vectors</h2>
 +
 +
<p>Main article:&nbsp;<a href="https://en.wikipedia.org/wiki/Vectors_in_gene_therapy" title="Vectors in gene therapy">Vectors in gene therapy</a></p>
 +
 +
<p>The delivery of DNA into cells can be accomplished by multiple&nbsp;<a href="https://en.wikipedia.org/wiki/Vectors_in_Gene_Therapy" title="Vectors in Gene Therapy">methods</a>. The two major classes are&nbsp;<a href="https://en.wikipedia.org/wiki/Recombinant_virus" title="Recombinant virus">recombinant viruses</a>&nbsp;(sometimes called biological nanoparticles or viral vectors) and&nbsp;<a href="https://en.wikipedia.org/wiki/Naked_DNA" title="Naked DNA">naked DNA</a>&nbsp;or DNA complexes (non-viral methods).</p>
 +
 +
<h3>Viruses</h3>
 +
 +
<p>Main article:&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_vector" title="Viral vector">Viral vector</a></p>
 +
 +
<p>In order to&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_replication" title="Viral replication">replicate</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Virus" title="Virus">viruses</a>&nbsp;introduce their genetic material into the host cell, tricking the host&#39;s cellular machinery into using it as blueprints for viral proteins.&nbsp;<a href="https://en.wikipedia.org/wiki/Retrovirus" title="Retrovirus">Retroviruses</a>&nbsp;go a stage further by having their genetic material copied into the genome of the host cell. Scientists exploit this by substituting a virus&#39;s genetic material with therapeutic DNA. (The term &#39;DNA&#39; may be an oversimplification, as some viruses contain RNA, and gene therapy could take this form as well.) A number of viruses have been used for human gene therapy, including&nbsp;<a href="https://en.wikipedia.org/wiki/Retrovirus" title="Retrovirus">retroviruses</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Adenovirus" title="Adenovirus">adenoviruses</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Herpes_simplex_virus" title="Herpes simplex virus">herpes simplex</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Vaccinia_virus" title="Vaccinia virus">vaccinia</a>, and&nbsp;<a href="https://en.wikipedia.org/wiki/Adeno-associated_virus" title="Adeno-associated virus">adeno-associated virus</a>.<sup><a href="https://en.wikipedia.org/wiki/Gene_therapy#cite_note-JGenMed_Database-4">[4]</a></sup>&nbsp;Like the genetic material (DNA or RNA) in viruses, therapeutic DNA can be designed to simply serve as a temporary blueprint that is degraded naturally or (at least theoretically) to enter the host&#39;s genome, becoming a permanent part of the host&#39;s DNA in infected cells.</p>
 +
 +
<h3>Non-viral</h3>
 +
 +
<p>Non-viral methods present certain advantages over viral methods, such as large scale production and low host&nbsp;<a href="https://en.wikipedia.org/wiki/Immunogenicity" title="Immunogenicity">immunogenicity</a>. However, non-viral methods initially produced lower levels of&nbsp;<a href="https://en.wikipedia.org/wiki/Transfection" title="Transfection">transfection</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Gene_expression" title="Gene expression">gene expression</a>, and thus lower therapeutic efficacy. Later technology remedied this deficiency.<sup>[<em><a href="https://en.wikipedia.org/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></em>]</sup></p>
 +
 +
<p><a href="https://en.wikipedia.org/wiki/Vectors_in_Gene_Therapy#Non-viral_methods" title="Vectors in Gene Therapy">Methods for non-viral gene therapy</a>&nbsp;include the injection of naked DNA,&nbsp;<a href="https://en.wikipedia.org/wiki/Electroporation" title="Electroporation">electroporation</a>, the&nbsp;<a href="https://en.wikipedia.org/wiki/Gene_gun" title="Gene gun">gene gun</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Sonoporation" title="Sonoporation">sonoporation</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Magnetofection" title="Magnetofection">magnetofection</a>, the use of&nbsp;<a href="https://en.wikipedia.org/wiki/Oligonucleotide" title="Oligonucleotide">oligonucleotides</a>, lipoplexes, dendrimers, and inorganic nanoparticles.</p>

Latest revision as of 22:13, 29 November 2018

Gene therapy using an adenovirus vector. In some cases, the adenovirus will insert the new gene into a cell. If the treatment is successful, the new gene will make a functional protein to treat a disease.

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.[1][2] The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989.[3] The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.

Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.[4]

Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients.[5] Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Approaches

Following early advances in genetic engineering of bacteria, cells, and small animals, scientists started considering how to apply it to medicine. Two main approaches were considered – replacing or disrupting defective genes.[28] Scientists focused on diseases caused by single-gene defects, such as cystic fibrosishaemophiliamuscular dystrophythalassemia, and sickle cell anemiaGlybera treats one such disease, caused by a defect in lipoprotein lipase.[27]

DNA must be administered, reach the damaged cells, enter the cell and either express or disrupt a protein.[29] Multiple delivery techniques have been explored. The initial approach incorporated DNA into an engineered virus to deliver the DNA into a chromosome.[30][31] Naked DNA approaches have also been explored, especially in the context of vaccine development.[32]

Generally, efforts focused on administering a gene that causes a needed protein to be expressed. More recently, increased understanding of nuclease function has led to more direct DNA editing, using techniques such as zinc finger nucleases and CRISPR. The vector incorporates genes into chromosomes. The expressed nucleases then knock out and replace genes in the chromosome. As of 2014 these approaches involve removing cells from patients, editing a chromosome and returning the transformed cells to patients.[33]

Gene editing is a potential approach to alter the human genome to treat genetic diseases,[34] viral diseases,[35] and cancer.[36] As of 2016 these approaches were still years from being medicine.[37][38]

Vectors

Main article: Vectors in gene therapy

The delivery of DNA into cells can be accomplished by multiple methods. The two major classes are recombinant viruses (sometimes called biological nanoparticles or viral vectors) and naked DNA or DNA complexes (non-viral methods).

Viruses

Main article: Viral vector

In order to replicateviruses introduce their genetic material into the host cell, tricking the host's cellular machinery into using it as blueprints for viral proteins. Retroviruses go a stage further by having their genetic material copied into the genome of the host cell. Scientists exploit this by substituting a virus's genetic material with therapeutic DNA. (The term 'DNA' may be an oversimplification, as some viruses contain RNA, and gene therapy could take this form as well.) A number of viruses have been used for human gene therapy, including retrovirusesadenovirusesherpes simplexvaccinia, and adeno-associated virus.[4] Like the genetic material (DNA or RNA) in viruses, therapeutic DNA can be designed to simply serve as a temporary blueprint that is degraded naturally or (at least theoretically) to enter the host's genome, becoming a permanent part of the host's DNA in infected cells.

Non-viral

Non-viral methods present certain advantages over viral methods, such as large scale production and low host immunogenicity. However, non-viral methods initially produced lower levels of transfection and gene expression, and thus lower therapeutic efficacy. Later technology remedied this deficiency.[citation needed]

Methods for non-viral gene therapy include the injection of naked DNA, electroporation, the gene gunsonoporationmagnetofection, the use of oligonucleotides, lipoplexes, dendrimers, and inorganic nanoparticles.